Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kai Simons

Showing results (141-150 of 149) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 149 results.
Kidney International|November 5, 2019
Integrative analysis of prognostic biomarkers derived from multiomics panels helps discrimination of chronic kidney disease trajectories in people with type 2 diabetesMichael Kammer, Andreas Heinzel, Jill A Willency, et al.
Nature Metabolism|June 29, 2021
Multi-omics profiling of living human pancreatic islet donors reveals heterogeneous beta cell trajectories towards type 2 diabetesLeonore Wigger, Marko Barovic, Andreas-David Brunner, et al.
Cell|January 13, 2018
Modulation of Myelopoiesis Progenitors Is an Integral Component of Trained ImmunityIoannis Mitroulis, Klara Ruppova, Baomei Wang, et al.
Journal of Lipid Research|July 23, 2023
Cholesteryl hemiazelate identified in CVD patients causes in vitro and in vivo inflammationNeuza Domingues, Joana Gaifem, Rune Matthiesen, et al.
Nature Communications|September 26, 2019
Genetic architecture of human plasma lipidome and its link to cardiovascular diseaseRubina Tabassum, Joel T Rämö, Pietari Ripatti, et al.
Nature Communications|May 28, 2026
A lipidomics roadmap: from basic research to societal challengesMaria Fedorova, Anne K Bendt, Justine Bertrand-Michel, et al.
Diabetologia|June 10, 2021
Replication and cross-validation of type 2 diabetes subtypes based on clinical variables: an IMI-RHAPSODY studyRoderick C Slieker, Louise A Donnelly, Hugo Fitipaldi, et al.
Diabetes|August 11, 2021
Distinct Molecular Signatures of Clinical Clusters in People With Type 2 Diabetes: An IMI-RHAPSODY StudyRoderick C Slieker, Louise A Donnelly, Hugo Fitipaldi, et al.
Nature Communications|May 3, 2023
Identification of biomarkers for glycaemic deterioration in type 2 diabetesRoderick C Slieker, Louise A Donnelly, Elina Akalestou, et al.
Pageof 15

Showing results (141-150 of 149) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 149 results.
Kidney International|November 5, 2019
Integrative analysis of prognostic biomarkers derived from multiomics panels helps discrimination of chronic kidney disease trajectories in people with type 2 diabetesMichael Kammer, Andreas Heinzel, Jill A Willency, et al.
Nature Metabolism|June 29, 2021
Multi-omics profiling of living human pancreatic islet donors reveals heterogeneous beta cell trajectories towards type 2 diabetesLeonore Wigger, Marko Barovic, Andreas-David Brunner, et al.
Cell|January 13, 2018
Modulation of Myelopoiesis Progenitors Is an Integral Component of Trained ImmunityIoannis Mitroulis, Klara Ruppova, Baomei Wang, et al.
Journal of Lipid Research|July 23, 2023
Cholesteryl hemiazelate identified in CVD patients causes in vitro and in vivo inflammationNeuza Domingues, Joana Gaifem, Rune Matthiesen, et al.
Nature Communications|September 26, 2019
Genetic architecture of human plasma lipidome and its link to cardiovascular diseaseRubina Tabassum, Joel T Rämö, Pietari Ripatti, et al.
Nature Communications|May 28, 2026
A lipidomics roadmap: from basic research to societal challengesMaria Fedorova, Anne K Bendt, Justine Bertrand-Michel, et al.
Diabetologia|June 10, 2021
Replication and cross-validation of type 2 diabetes subtypes based on clinical variables: an IMI-RHAPSODY studyRoderick C Slieker, Louise A Donnelly, Hugo Fitipaldi, et al.
Diabetes|August 11, 2021
Distinct Molecular Signatures of Clinical Clusters in People With Type 2 Diabetes: An IMI-RHAPSODY StudyRoderick C Slieker, Louise A Donnelly, Hugo Fitipaldi, et al.
Nature Communications|May 3, 2023
Identification of biomarkers for glycaemic deterioration in type 2 diabetesRoderick C Slieker, Louise A Donnelly, Elina Akalestou, et al.
Pageof 15